Beijing Hotgen Biotech Co.,Ltd.

Hotgen  Fetal Fibronectin (fFN) Test Cassette

Hotgen  fFN CG kit is an accurate and rapid immunochromatografic test for the  qualitative determination of Fetal Fibronectin (fFN) in human cervicoviginal  secretions as an tool for risk estimation of preterm labor. 

fFN:  A specific biomarker for risk estimation of preterm delivery 

Fetal  Fibronectin (fFN) is a protein that acts as a "glue" during pregnancy, attaching  amniotic sac to the lining of uterus. Disruption of this interface causes the  release of fFN into cervical/vaginal secretions.

As  a new-found specific biomarker for preterm delivery, fFN is highly associated  with risk of preterm delivery when present  in cervicovaginal secretions.  

fFN  testing is approved by FDA for use in women from weeks 22 to 35 of  pregnancy. 

A  positive fFN  test result indicates that a woman have high risk of preterm  labor, although it can't tell for sure that she will go into labor soon. A  negative result means that preterm delivery will 98% unlikely happen to the  pregnant woman within one to two weeks, and the test can be repeated weekly for  women who remain at high risk.

Benefits  of fFN test in summary:

Specific  biomarker for risk assessment of preterm labor in women from 22 to 35 weeks of  pregnancy

Positive  result indicates high risk of preterm delivery

Negative  result can almost rule out the possibility of preterm delivery within two  weeks

Help  avoid unnecessary intervention and  hospitalizations

Hotgen Fetal  Fibronectin Test Principle

Colloidal  gold immunochromatographic method

Hotgen Fetal  Fibronectin Kit Features

Qualitative  fFN measurement

Rapid,  accurate, lab quality results within minutes

Ready-to-use  reagents

Long  shelf life

Easy  storage at room temperature

Single  dose format: run only the test you need